Topical and intravitreous administration of cationic nanoemulsions to deliver antisense oligonucleotides directed towards VEGF KDR receptors to the eye

Hagigit T., Abdulrazik M., Orucov F., Valamanesh F., Lambert M., Lambert G., Behar-Cohen F., Benita S.

2010
Journal of Controlled Release

View publication

Therapeutic Area

Back of the eye (BOTE)
Categories

Preclinical development

Affiliations

Department of Pharmaceutics, The School of Pharmacy, The Hebrew University of Jerusalem, Jerusalem, Israel; Department of Ophthalmology, Hadassah, Hebrew University Medical Center, Jerusalem, Israel; INSERM U598, Paris, France; Novagali, Evry, France; Rothschild Foundation, Paris, France

Related Publications

Aging-associated changes of optical coherence tomography-measured ganglion cell-related retinal layer thickness and visual sensitivity in normal Japanese

Iwase A., Higashide T., Fujii M., Ohno Y., Tanaka Y., Kikawa T., Araie M.

Atropine Ophthalmic Solution to Reduce Myopia Progression in Pediatric Subjects: The Randomized, Double-Blind Multicenter Phase II APPLE Study

Chia A, Ngo C, Choudry N, Yamakawa Y, Tan D

Efficacy of lutein supplements on macular pigment optical density in highly myopic individuals: A randomized controlled trial

Yoshida T.; Takagi Y.; Igarashi-Yokoi T.; Ohno-Matsui K.

View all Back of the eye (BOTE) publications

Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022